Nuveen New York Select Tax-Free Income Portfolio

NYSE:NXN

11.3101 (USD) • At close April 17, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22010 Q42010 Q2
Revenue 0.8050.8561.0210.9360.9030.9390.9961.0491.0671.0760.961.0991.1151.151.2161.1981.2421.2331.2231.2211.2991.3061.321.39300
Cost of Revenue 0.0752.884000000000.087000000000000000
Gross Profit 0.73-2.0291.0210.9360.9030.9390.9961.0491.0671.0760.8741.0991.1151.151.2161.1981.2421.2331.2231.2211.2991.3061.321.39300
Gross Profit Ratio 0.907-2.371111111110.91111111111111100
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 00.0760.1020.1090.1120.1140.1150.1090.1230.1080.0550.1090.1150.1130.1180.120.1180.1160.1170.1190.1150.1130.1030.11900
Selling & Marketing Expenses 00000000000000000000000000
SG&A -1.4241.50.1020.1090.1120.1140.1150.1090.1230.1080.0550.1090.1150.1130.1180.120.1180.1160.1170.1190.1150.1130.1030.11900
Other Expenses 02.989000000001.342000000000000000
Operating Expenses -1.4244.4890.8974.9570.1120.1140.3980.8071.8121.16-1.3420.7461.2670.682.4940.3330.6720.9320.3241.72614.0660.8721.35800
Operating Income 2.153-6.5170.9190.8280.7910.8250.880.9390.9450.9692.2150.990.9991.0371.0981.0791.1251.1171.1061.1021.1831.1931.2171.27300
Operating Income Ratio 2.675-7.6170.9010.8840.8760.8780.8840.8960.8850.92.3060.9010.8960.9020.9030.90.9050.9060.9040.9030.9110.9130.9220.91400
Total Other Income Expenses Net -0.0017.352-0.795-4.848-2.0280.0970.5140.917-1.6941.264-0.004-0.641-1.1570.786-2.3820.4470.786-0.8190.4371.8431.114-3.955-0.7711.47500
Income Before Tax 2.1520.8350.124-4.02-1.2370.9221.3941.856-0.7492.2322.2110.349-0.1581.823-1.2841.5261.9110.2981.5442.9452.297-2.7620.4462.74800
Income Before Tax Ratio 2.6730.9760.121-4.294-1.370.9821.41.77-0.7022.0742.3020.318-0.1421.585-1.0561.2731.5380.2421.2622.4121.769-2.1150.3381.97300
Income Tax Expense 0-0-0.795-4.848000.5140.917-1.6941.2640.483-0.641-1.1570.786-2.3820.4470.786-0.8190.4371.8431.114-3.955-0.7711.47500
Net Income 2.1520.8350.124-4.02-1.2370.9221.3941.856-0.7492.2322.2110.349-0.1581.823-1.2841.5261.9110.2981.5442.9452.297-2.7620.4462.74800
Net Income Ratio 2.6730.9760.121-4.294-1.370.9821.41.77-0.7022.0742.3020.318-0.1421.585-1.0561.2731.5380.2421.2622.4121.769-2.1150.3381.97300
EPS 0.550.210.032-1.02-0.230.230.360.48-0.1910.560.560.089-0.040.46-0.320.380.480.0760.40.760.58-0.70.1140.700
EPS Diluted 0.550.210.032-1.02-0.230.230.360.48-0.1910.560.560.089-0.040.46-0.320.380.480.0760.40.760.58-0.70.1140.700
EBITDA 2.1530.83500000000000000-00-0000-01.47500
EBITDA Ratio 2.6750.9760000000000000000000001.05900